SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Jefferies Maintains Buy on Arena Pharmaceuticals, Raises Price Target to $69

Jefferies maintains Arena Pharmaceuticals (NASDAQ:ARNA) with a Buy and raises the price target from $62 to $69.

Benzinga · 05/22/2020 13:21

Jefferies maintains Arena Pharmaceuticals (NASDAQ:ARNA) with a Buy and raises the price target from $62 to $69.